LI
Liontrust Investment Partners LLP cut its MXCT stake below 5%
Liontrust Investment Partners LLP reported owning 4.9% of Maxcyte, Inc. (MXCT) (5,081,403 shares) in a Schedule 13D filed Nov 2, 2026.
A 13D means the holder may push for changes at the company.